本文選題：鼻咽癌 + SA蛋白��； 參考：《臨床檢驗雜志》2014年04期

【摘要】：目的探討鼻咽癌患者血漿中S100A8和S100A9蛋白水平與臨床分期及血漿EB病毒VCA-IgA抗體的相關性。方法用ELISA法檢測鼻咽癌患者(Ⅱ期36例,Ⅲ期104例,Ⅳ期104例)和104例體檢健康者血漿中S100A8、S100A9蛋白濃度和EB病毒VCA-IgA抗體水平,用SPSS 16.0統(tǒng)計軟件進行數(shù)據(jù)分析。結果鼻咽癌患者血漿中S100A8、S100A9蛋白濃度分別為0.44(0.25,0.78)ng/mL和202.71(185.79,238.54)pg/mL,顯著高于體檢健康者0.29(0.18,0.44)ng/mL和192.43(170.66,193.42)pg/mL(P均0.05)。Ⅱ、Ⅲ、Ⅳ期鼻咽癌患者血漿S100A8、S100A9蛋白濃度均高于體檢健康者(P均0.05),且Ⅱ、Ⅲ期鼻咽癌患者血漿中S100A8、S100A9蛋白濃度高于Ⅳ期(P0.05);Ⅲ期S100A9蛋白濃度高于Ⅱ期(P0.05)。相關分析結果顯示,鼻咽癌患者血漿中S100A8、S100A9蛋白濃度與EB病毒VCA-IgA抗體水平無相關性(r分別為-0.04,-0.07,P均0.05)。結論鼻咽癌患者血漿中S100A8和S100A9蛋白水平升高,且與臨床分期有關。
[Abstract]:Objective to investigate the correlation between plasma S100A8 and S100A9 protein levels and clinical stage and EB virus VCA-IgA antibody in patients with nasopharyngeal carcinoma (NPC). Methods the concentration of S100A8 S100A9 protein and the level of EB virus VCA-IgA antibody in plasma of patients with nasopharyngeal carcinoma (36 cases in stage 鈪，

本文編號：2056880